Abstract
Introduction: There is still a lack of availability of high-quality multiparametric magnetic resonance imaging (mpMRI) interpreted by experienced uro-radiologists to rule out clinically significant PC (csPC). Consequently, we developed a new imaging method based on computed tomographic ultrasound (US) supported by artificial neural network analysis (ANNA). Methods: Two hundred and two consecutive patients with visible mpMRI lesions were scanned and recorded by robotic CT-US during mpMRI-TRUS biopsy. Only significant index lesions (ISUP ≥2) verified by whole-mount pathology were retrospectively analyzed. Their visibility was reevaluated by 2 blinded investigators by grayscale US and ANNA. Results: In the cohort, csPC was detected in 105 cases (52%) by mpMRI-TRUS biopsy. Whole-mount histology was available in 44 cases (36%). In this subgroup, mean PSA level was 8.6 ng/mL, mean prostate volume was 33 cm3, and mean tumor volume was 0.5 cm3. Median PI-RADS and ISUP of index lesions were 4 and 3, respectively. Index lesions were visible in grayscale US and ANNA in 25 cases (57%) and 30 cases (68%), respectively. Combining CT-US-ANNA, we detected index lesions in 35 patients (80%). Conclusions: The first results of multiparametric CT-US-ANNA imaging showed promising detection rates in patients with csPC. US imaging with ANNA has the potential to complement PC diagnosis.
References
1.
Holm
HH
, Gammelgaard
J
. Ultrasonically guided precise needle placement in the prostate and the seminal vesicles
. J Urol
. 1981 Mar
;125
(3
):385
–7
. .2.
Mottet
N
, Cornford
P
, van den Bergh
RCN
, Briers
E
, De Santis
M
, Fanti
S
, Edition Presented at the EAU Annual Congress Amsterdam; 2020
. Amsterdam
: EAU Guidelines
; 2020
.3.
Lee
F
, Siders
DB
, Torp-Pedersen
ST
, Kirscht
JL
, McHugh
TA
, Mitchell
AE
. Prostate cancer: transrectal ultrasound and pathology comparison. A preliminary study of outer gland (peripheral and central zones) and inner gland (transition zone) cancer
. Cancer
. 1991 Feb 15
;67
(4 Suppl
):1132
–42
. .4.
Brock
M
, von Bodman
C
, Sommerer
F
, Löppenberg
B
, Klein
T
, Deix
T
, Comparison of real-time elastography with grey-scale ultrasonography for detection of organ-confined prostate cancer and extra capsular extension: a prospective analysis using whole mount sections after radical prostatectomy
. BJU Int
. 2011 Oct
;108
(8 Pt 2
):E217
–22
. .5.
Loch
T
, Leuschner
I
, Genberg
C
, Weichert-Jacobsen
K
, Küppers
F
, Yfantis
E
, Artificial neural network analysis (ANNA) of prostatic transrectal ultrasound
. Prostate
. 1999 May 15
;39
(3
):198
–204
. .6.
Xie
Y
, Tokas
T
, Grabski
B
, Loch
T
. Internal fusion: exact correlation of transrectal ultrasound images of the prostate by detailed landmarks over time for targeted biopsies or follow-up
. World J Urol
. 2017 Dec 27
;36
(5
):693
–8
.7.
Kaufmann
S
, Kruck
S
, Kramer
U
, Gatidis
S
, Stenzl
A
, Roethke
M
, Direct comparison of targeted MRI-guided biopsy with systematic transrectal ultrasound-guided biopsy in patients with previous negative prostate biopsies
. Urol Int
. 2015
;94
(3
):319
–25
. .8.
Ahmed
HU
, El-Shater Bosaily
A
, Brown
LC
, Gabe
R
, Kaplan
R
, Parmar
MK
, Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
. Lancet
. 2017 Feb 25
;389
(10071
):815
–22
. .9.
Weinreb
JC
, Barentsz
JO
, Choyke
PL
, Cornud
F
, Haider
MA
, Macura
KJ
, PI-RADS Prostate Imaging - Reporting and Data System: 2015, version 2
. Eur Urol
. 2016 Jan
;69
(1
):16
–40
. .10.
Scheidler
J
, Weöres
I
, Brinkschmidt
C
, Zeitler
H
, Panzer
S
, Scharf
M
, Diagnosis of prostate cancer in patients with persistently elevated PSA and tumor-negative biopsy in ambulatory care: performance of MR imaging in a multi-reader environment
. Rofo
. 2012 Feb
;184
(2
):130
–5
. .11.
Bass
EJ
, Pantovic
A
, Connor
M
, Gabe
R
, Padhani
AR
, Rockall
A
, A systematic review and meta-analysis of the diagnostic accuracy of biparametric prostate MRI for prostate cancer in men at risk
. Prostate Cancer Prostatic Dis
. 2020 Nov 20
. Online ahead of print.12.
Kaufmann
S
, Mischinger
J
, Amend
B
, Rausch
S
, Adam
M
, Scharpf
M
, First report of robot-assisted transperineal fusion versus off-target biopsy in patients undergoing repeat prostate biopsy
. World J Urol
. 2017 Jul
;35
(7
):1023
–9
. .13.
Mischinger
J
, Kaufmann
S
, Russo
GI
, Harland
N
, Rausch
S
, Amend
B
, Targeted vs systematic robot-assisted transperineal magnetic resonance imaging-transrectal ultrasonography fusion prostate biopsy
. BJU Int
. 2018 May
;121
(5
):791
–8
. .14.
Tokas
T
, Grabski
B
, Paul
U
, Baurle
L
, Loch
T
. A 12-year follow-up of ANNA/C-TRUS image-targeted biopsies in patients suspicious for prostate cancer
. World J Urol
. 2017 Dec 23
;36
(5
):699
–704
.15.
Barentsz
JO
, Richenberg
J
, Clements
R
, Choyke
P
, Verma
S
, Villeirs
G
, ESUR prostate MR guidelines 2012
. Eur Radiol
. 2012 Apr
;22
(4
):746
–57
. .16.
Woo
S
, Suh
CH
, Kim
SY
, Cho
JY
, Kim
SH
. Head-to-head comparison between high- and standard-b-value DWI for detecting prostate cancer: a systematic review and meta-analysis
. AJR Am J Roentgenol
. 2018 Jan
;210
(1
):91
–100
. .17.
Loeb
S
, Bjurlin
MA
, Nicholson
J
, Tammela
TL
, Penson
DF
, Carter
HB
, Overdiagnosis and overtreatment of prostate cancer
. Eur Urol
. 2014 Jun
;65
(6
):1046
–55
. .18.
Kasivisvanathan
V
, Rannikko
AS
, Borghi
M
, Panebianco
V
, Mynderse
LA
, Vaarala
MH
, MRI-targeted or standard biopsy for prostate-cancer diagnosis
. N Engl J Med
. 2018 May 10
;378
(19
):1767
–77
. .19.
Girouin
N
, Mège-Lechevallier
F
, Tonina Senes
A
, Bissery
A
, Rabilloud
M
, Maréchal
JM
, Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria: is it reasonable?
Eur Radiol
. 2007 Jun
;17
(6
):1498
–509
. .20.
Nogueira
L
, Wang
L
, Fine
SW
, Pinochet
R
, Kurta
JM
, Katz
D
, Focal treatment or observation of prostate cancer: pretreatment accuracy of transrectal ultrasound biopsy and T2-weighted MRI
. Urology
. 2010 Feb
;75
(2
):472
–7
. .21.
Hansen
NL
, Koo
BC
, Gallagher
FA
, Warren
AY
, Doble
A
, Gnanapragasam
V
, Comparison of initial and tertiary centre second opinion reads of multiparametric magnetic resonance imaging of the prostate prior to repeat biopsy
. Eur Radiol
. 2017 Jun
;27
(6
):2259
–66
. .22.
Sadowski
EA
, Bennett
LK
, Chan
MR
, Wentland
AL
, Garrett
AL
, Garrett
RW
, Nephrogenic systemic fibrosis: risk factors and incidence estimation
. Radiology
. 2007 Apr
;243
(1
):148
–57
. .23.
Muller
BG
, Shih
JH
, Sankineni
S
, Marko
J
, Rais-Bahrami
S
, George
AK
, Prostate cancer: interobserver agreement and accuracy with the revised prostate imaging reporting and data system at multiparametric MR imaging
. Radiology
. 2015 Dec
;277
(3
):741
–50
. .24.
Kasel-Seibert
M
, Lehmann
T
, Aschenbach
R
, Guettler
FV
, Abubrig
M
, Grimm
MO
, Assessment of PI-RADS v2 for the detection of prostate cancer
. Eur J Radiol
. 2016 Apr
;85
(4
):726
–31
. .25.
Rosenkrantz
AB
, Ginocchio
LA
, Cornfeld
D
, Froemming
AT
, Gupta
RT
, Turkbey
B
, Interobserver reproducibility of the PI-RADS version 2 Lexicon: a multicenter study of six experienced prostate radiologists
. Radiology
. 2016 Sep
;280
(3
):793
–804
. .26.
Zhao
C
, Gao
G
, Fang
D
, Li
F
, Yang
X
, Wang
H
, The efficiency of multiparametric magnetic resonance imaging (mpMRI) using PI-RADS Version 2 in the diagnosis of clinically significant prostate cancer
. Clin Imaging
. 2016 Sep–Oct
;40
(5
):885
–8
. .27.
Sonn
GA
, Fan
RE
, Ghanouni
P
, Wang
NN
, Brooks
JD
, Loening
AM
, Prostate magnetic resonance imaging interpretation varies substantially across radiologists
. Eur Urol Focus
. 2019 Jul
;5
(4
):592
–9
. .28.
Hodge
KK
, McNeal
JE
, Terris
MK
, Stamey
TA
. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate
. J Urol
. 1989 Jul
;142
(1
):71
–5
; discussion 74–5. .29.
Postema
A
, Mischi
M
, de la Rosette
J
, Wijkstra
H
. Multiparametric ultrasound in the detection of prostate cancer: a systematic review
. World J Urol
. 2015 Nov
;33
(11
):1651
–9
. .30.
Loch
T
. Computerized transrectal ultrasound (C-TRUS) of the prostate: detection of cancer in patients with multiple negative systematic random biopsies
. World J Urol
. 2007 Aug
;25
(4
):375
–80
. .31.
Grabski
B
, Baeurle
L
, Loch
A
, Wefer
B
, Paul
U
, Loch
T
. Computerized transrectal ultrasound of the prostate in a multicenter setup (C-TRUS-MS): detection of cancer after multiple negative systematic random and in primary biopsies
. World J Urol
. 2011 Oct
;29
(5
):573
–9
. .32.
Tokas
T
, Grabski
B
, Paul
U
, Bäurle
L
, Loch
T
. A 12-year follow-up of ANNA/C-TRUS image-targeted biopsies in patients suspicious for prostate cancer
. World J Urol
. 2018
;36
(5
):699
–704
. .33.
Garcia-Reyes
K
, Nguyen
HG
, Zagoria
RJ
, Shinohara
K
, Carroll
PR
, Behr
SC
, Impact of lesion visibility on transrectal ultrasound on the prediction of clinically significant prostate cancer (Gleason Score 3 + 4 or Greater) with transrectal ultrasound-magnetic resonance imaging fusion biopsy
. J Urol
. 2018 Mar
;199
(3
):699
–705
. .34.
Lee
HY
, Lee
HJ
, Byun
SS
, Lee
SE
, Hong
SK
, Kim
SH
. Classification of focal prostatic lesions on transrectal ultrasound (TRUS) and the accuracy of TRUS to diagnose prostate cancer
. Korean J Radiol
. 2009 May–Jun
;10
(3
):244
–51
. .35.
Nelson
ED
, Slotoroff
CB
, Gomella
LG
, Halpern
EJ
. Targeted biopsy of the prostate: the impact of color Doppler imaging and elastography on prostate cancer detection and Gleason score
. Urology
. 2007 Dec
;70
(6
):1136
–40
. .36.
Xie
SW
, Li
HL
, Du
J
, Xia
JG
, Guo
YF
, Xin
M
, Contrast-enhanced ultrasonography with contrast-tuned imaging technology for the detection of prostate cancer: comparison with conventional ultrasonography
. BJU Int
. 2012 Jun
;109
(11
):1620
–6
. .37.
Drost
FH
, Osses
DF
, Nieboer
D
, Steyerberg
EW
, Bangma
CH
, Roobol
MJ
, Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer
. Cochrane Database Syst Rev
. 2019 Apr 25
;4
:CD012663
. .38.
Wiemer
L
, Hollenbach
M
, Heckmann
R
, Kittner
B
, Plage
H
, Reimann
M
, Evolution of targeted prostate biopsy by adding micro-ultrasound to the magnetic resonance imaging pathway
. Eur Urol Focus
. 2020
. Epub ahead of print.© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
